Patents by Inventor Petar Bibulic

Petar Bibulic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SOLID STATE FORMS OF ENSARTINIB AND ENSARTINIB SALTS
    Publication number: 20230227413
    Abstract: The present disclosure encompasses solid state forms and co-crystals of Ensartinib and of Ensartinib salts, in embodiments crystalline polymorphs of Ensartinib and of Ensartinib salts and co-crystals, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: August 3, 2021
    Publication date: July 20, 2023
    Inventors: Petar Bibulic, Sanja Matecic Musanic, Lorena Kordic
  • SOLID STATE FORMS OF APROCITENTAN AND PROCESS FOR PREPARATION THEREOF
    Publication number: 20230167090
    Abstract: The present disclosure encompasses novel solid state forms of Aprocitentan, Aprocitentan salts and Aprocitentan co-crystals, processes for preparation thereof, and pharmaceutical compositions thereof.
    Type: Application
    Filed: May 21, 2021
    Publication date: June 1, 2023
    Inventors: Petar Bibulic, Sanja Matecic Musanic
  • SOLID STATE FORMS OF N-[2-(2-{4-[2-(6,7-DIMETHOXY-3,4-DIHYDRO-2(1H)-ISOQUINOLINYL)ETHYL]PHENYL}-2H-TETRAZOL-5-YL)-4,5- DIMETHOXYPHENYL]-4-OXO-4H-CHROMENE-2-CARBOXAMIDE AND OF ITS MESYLATE SALT
    Publication number: 20220135548
    Abstract: The present disclosure relates to solid state forms of Encequidar (previously referred to as HM-30181A) base, Encequidar ((HM-30181A) mesylate, co-crystals of Encequidar (HM-30181A) mesylate, processes for preparation thereof, as well as pharmaceutical compositions including the same.
    Type: Application
    Filed: February 14, 2020
    Publication date: May 5, 2022
    Inventors: Petar Bibuliç, Dijana Skalec Samec, Marina Marinkovic, Jasna Dogan